WednesdayJun 13, 2018 12:09 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Focusing on Delivery of Bioactive Substances via Oral Ingestion

Lexaria has its patented DehydraTECH™ nutrient infusion technology This technology has patent protection for cannabidiol and all other non-psychoactive cannabinoids DehydraTECH™ technology provides greater bio-absorption Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is a worldwide leader in enhancing the gastro-intestinal delivery of edible cannabinoid products. The company has its patented nutrient infusion technology called DehydraTECH™. This technology significantly improves the body’s ability to absorb cannabinoids, vitamins, nonsteroidal anti-inflammatory drugs (NSAIDs), PDE5 inhibitors, nicotine, drugs, supplements and other beneficial molecules. Lexaria Bioscience is headquartered in Kelowna, British Columbia. Lexaria has patents granted in the United States and Australia for applications of its…

Continue Reading

WednesdayJun 13, 2018 11:28 am

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Extends Share Warrants Expiry amid Growing Alternative Medicine Popularity

PreveCeutical moves on recent stock split to boost share appeal Company’s organic therapeutics aim to relieve maladies for patients with diabetes, brain injuries and other conditions Alternative medicines market expected to generate nearly $200 billion in revenues by 2025 PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) continues working to shore up its share appeal while seeking remedies for a variety of physical ailments through its nature-centric research to help patients with type 2 diabetes and obesity, mild traumatic brain injury, cancer and pervasive pain. PreveCeutical Medical completed a forward stock split last month on the basis of five…

Continue Reading

MondayJun 11, 2018 1:02 pm

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Set to Capitalize on Growth of Dietary Supplement, Drug Delivery Markets

Two separate market research reports predict 7.0 percent and 2.9 percent CAGR, respectively, in PreveCeutical’s areas of operation PreveCeutical developing Sol-Gel, an innovative medicine delivery platform Health sciences company PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) is uniquely positioned to capitalize of the growth of two different markets in which it currently operates: dietary supplements and drug delivery systems. Two separate market research reports indicated recently that these sectors are expected to grow a projected 7.0 percent and 2.9 percent, respectively, over the next five years. In a report published in May, Technavio estimated that the global dietary…

Continue Reading

FridayJun 08, 2018 12:33 pm

Marijuana Company of America, Inc. (MCOA) Building a Vertically Integrated Hemp Company amid Growing Advocacy for Versatile Plant

Non-psychoactive hemp’s varied uses comprise $500 million-plus industry with billion-dollar reach JV binds partners in growing New Brunswick and Oregon hemp cultivation projects Support increasing for U.S. Congressional drive to legalize hemp Hemp advocates at Marijuana Company of America, Inc. (OTC: MCOA) are advancing cultivation projects that will give the company a significant supply of non-intoxicating cannabidiol (CBD) for market under the hempSMART and BeniHemp brands. The wholly owned hempSMART subsidiary strategically works to build share value through the distribution of CBD-based health and wellness products via a network marketing model, and BeniHemp offers hemp-derived CBD products to consumer retail…

Continue Reading

ThursdayMay 31, 2018 9:00 am

CBD Market Set for Huge Growth

PsychedelicNewsWire Editorial Coverage: In a fragile economic world, industries with significant growth forecast are certain to catch the eye of savvy investors looking for just the right place to be. Recent reports indicate that the cannabidiol (CBD) market is estimated to grow by 700 percent by 2020, and a report by market intelligence firm Hemp Business Journal projects that the CBD market will grow to $2.1 billion by 2020 (http://cnw.fm/7iczS), an astronomical jump in value compared to last year’s CBD market of $202 million. This news bodes well for hemp-focused companies such as Marijuana Company of America (OTC: MCOA) (MCOA…

Continue Reading

TuesdayMay 29, 2018 1:26 pm

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Adding Value to Nature-Identical Therapies Portfolio

Stock split, CSE listing show evidence of company’s shareholder commitment PreveCeutical balancing need for unique profit-building intellectual property with mission to offer affordable products to patients Manufacturer agreement, licensed shipments advance CBD therapy research Alternative medicines market valued at more than $40 billion PreveCeutical Medical Inc.’s (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) dedication to developing preventative medical therapies based on the identified health benefits of natural substances in controllable formulations that are both affordable to consumers and potentially profitable to investors is on display in the company’s recent shareholder-approved forward stock split and the opening of trade on the Canadian…

Continue Reading

ThursdayMay 24, 2018 9:00 am

CBD Solid Bedrock as US Heads Back to Industrial Hemp Roots

PsychedelicNewsWire Editorial Coverage: With the announcement in April of the Industrial Hemp Farming Act of 2018, the industry could be looking at a federal redefinition of hemp. Industrial hemp is a great source for CBD (cannabidiol), a non-psychoactive cannabinoid with numerous medical applications ranging (http://cnw.fm/7tqIy). U.S. market projections for hemp range from $1.9 to $2.1 billion within the next two years and could hit $3 billion by 2021, according to one industry analyst (http://cnw.fm/MLA5w). This is great news for well-positioned sector players such as Marijuana Company of America (OTC: MCOA) (MCOA Profile), which recently executed a sizeable hemp-cultivation JV agreement.…

Continue Reading

WednesdayMay 23, 2018 12:05 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Technology Boosts Prospects for Smoke-Free Nicotine Future

New FDA restrictions on Big Tobacco take effect Tobacco manufacturers turning to ‘reduced-risk’ products No edible nicotine products currently available DehydraTECH improves bio-absorption of nicotine taken orally Smoking may be a dying trend, but consumption of nicotine is not only very much alive; its longevity is assured by Big Tobacco’s foray into alternative tobacco and ‘reduced-risk’ products. Driven by increased public awareness and government policy, the pressure has been turned up on smokers to quit, and cigarette manufacturers are feeling the heat, as well. New regulations mandating warnings against the adverse health effects of smoking and the addictive power of…

Continue Reading

FridayMay 18, 2018 12:11 pm

Global Hemp Group, Inc. (CSE: GHG) (FRA: GHG) (OTC: GBHPF) Advancing in Oregon Cultivation of Versatile Hemp Plant

Joint venture with MCOA establishing hemp farms in U.S. and Canada CBD hemp propagation phase and the development of outdoor-indoor facilities to maintain year-round cycle Oregon farm covers 109 acres; greenhouses will add 19,296 square feet of indoor production space Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF), a company dedicated to building a portfolio of hemp-friendly businesses intent on producing the ancient crop renowned for its use in paper, textiles, rope and building materials, is celebrating the recent property acquisition and the advancement of its farming operations in Scio, Oregon. “Garden operations are well underway at the…

Continue Reading

TuesdayMay 15, 2018 12:37 pm

Global Hemp Group, Inc. (CSE: GHG) (FRA: GHG) (OTC: GBHPF) Pursuing Profitable Harvest in Niche Markets

Focused on growing strategic portfolio of industrial hemp-based companies Entered into joint venture with Marijuana Company of America, Inc. to purchase 109-acre farm in Oregon for cultivation of legal, high-yielding CBD from industrial hemp Hemp industry projected to reap $1.8 billion in sales by 2020, with growing political support 2018 growing season includes commercial hemp development projects at farms in Canada and Oregon Hemp cultivation company Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF) continues to execute its strategic growth plan with the recent purchase of 109 acres of prime agricultural land in Oregon with joint venture partner…

Continue Reading

PsychedelicNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 415.949.5050